ESG

PFU America unveils the ScanSnap iX2500 Receipt Edition, a new scanner with deep QuickBooks integration designed to end small business paperwork chaos.

Pella's 2026 report reveals a major shift in home design, where durability, well-being, and climate resilience are now prized over fleeting aesthetics.

HBW Resources hires advocacy expert Jeff Ostermayer as energy firms brace for the power surge from data centers, signaling a new front in policy wars.

New data reveals Orasis Pharma's Qlosi eye drops offer a 'pupil selective' approach to presbyopia, promising fewer side effects than rival treatments.

A health firm with falling stock doubles down on Bitcoin, raising eyebrows. Is this a savvy financial hedge or a dangerous distraction from its core mission?

Nextech's new Cora Scribe moves beyond generic AI, offering a deeply integrated tool for ophthalmology that promises to reduce burnout and improve patient care.

A new partnership combines radiation-free imaging with advanced AI analytics, aiming to revolutionize breast cancer detection and patient care.

A new partnership aims to integrate advanced battery tech and custom controls, accelerating the shift to zero-emission machinery in demanding sectors.

An oral drug for Huntington's disease shows early success, improving patient scores where a decline was expected, fueling hope for a breakthrough treatment.

CI Global Asset Management launches innovative funds combining crypto's growth and gold's stability, challenging traditional diversification with a 0% fee offer.

A pivotal FDA meeting moves a novel drug forward for Dementia with Lewy Bodies, a disease with no approved therapies, offering new hope to patients.

A new framework signals a major shift from message control to radical transparency. Here's why brands that embrace authenticity will win in a skeptical market.

ENNOVI's Tijuana expansion offers a key nearshoring solution for medical device makers, tackling complex regulations and streamlining North American supply chains.

A new report from a top analyst reveals how chaotic yard operations are silently draining profits and creating massive risks for shippers across the globe.

BioTalent Canada's latest awards highlight how inclusivity, diversity, and equity are becoming key drivers of innovation and profit in the bioscience sector.

New research provides the strongest human evidence that sleep actively clears toxic proteins linked to Alzheimer's, opening a new frontier for prevention.

A Norwegian firm's new AI software aims to reduce physician distractions and build trust, setting a new standard for cancer-detecting technology.

A new report reveals 84% of high-risk firms are unprepared for insider threats as state actors increasingly target the human factor within organizations.

Activist investor Farallon Capital pressures insurer T&D Holdings with a public blueprint for reform, demanding bold changes ahead of its 2026 vision.

A French biotech is advancing a novel class of drugs that don't just fight cravings but may reverse the deep-seated brain changes caused by addiction.